The Adolescent to Adult Patient-centered HIV Transition Study (ADAPT)
以患者为中心的青少年到成人艾滋病毒过渡研究 (ADAPT)
基本信息
- 批准号:9206304
- 负责人:
- 金额:$ 28.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-19 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:19 year oldAddressAdolescenceAdolescentAdultAdvocateAffectAfrica South of the SaharaAfricanAppointmentAreaCaringCharacteristicsChildChildhoodClinicClinicalCluster randomized trialContinuity of Patient CareCountryDataDevelopmentEducationEducational InterventionEgoEnrollmentEnsureEpidemiologyEquationEvaluationFacultyFocus GroupsFundingGovernmentHIVHIV InfectionsHIV-infected adolescentsHealthHealth PersonnelHealth care facilityHealthcare SystemsHumanIndividualInfectionInstitutesInstitutionInterventionLeadLettersLifeMarylandMeasuresMedicalModelingNigeriaNigerianOutcomeOutcome MeasureOwnershipParentsParticipantPathway interactionsPatient-Focused OutcomesPatientsProcessProviderPsychosocial FactorRandomizedRandomized Clinical TrialsResearchResourcesRoleServicesSiteSocial NetworkSocial SciencesSocial supportStructureSupport GroupsSupport SystemSystemTimeUniversitiesViral Load resultWorkadolescent patientagedarmbasedesigneffective interventionemerging adultexpectationexperiencefollow-upimprovedinnovationinsightlow and middle-income countriesmedical schoolsmedical specialtiespatient orientedpediatric human immunodeficiency viruspeerprimary outcomeprogramspsychosocialpublic health relevancerandomized trialresponsesatisfactionsecondary outcometoolvirology
项目摘要
One of the distinct challenges faced by emerging adults with HIV is the transition of their care from their long-
term pediatric HIV provider to treatment within an adult HIV program. While conceptually the transition from
pediatric to adult care may seem straightforward, the reality is that the transition often is a very difficult
process. The consequences of an unsuccessful transition can range from difficult to catastrophic. The
Adolescent to Adult Patient-centered HIV Transition (ADAPT) Study is a randomized trial of innovative
interventions targeting gaps in care that are major drivers of loss in the ART continuum of care cascade among
adolescents and increasing missed opportunities to engage adolescents into care. The specific aims of
ADAPT are: (a) to inform strategies for transition services in resource-limited settings; (b) to examine the
developmental, clinical, and other factors that predict a successful transition; and (c) to gain fundamental
insight on implementation barriers among African adolescents through the application of the ego-network
defined social support that will inform targets for structured intervention. Our multi-PI team includes strong
complementary expertise in pediatric and adolescent HIV care, epidemiology, and social science. ADAPT will
be conducted in central, southern, and northern Nigeria at selected PEPFAR sites supported by the Institute of
Human Virology, Nigeria. To address Aim 1 we will conduct six focus groups including: Adolescent patients,
parents and health care providers. To address aim 2, we will conduct a cluster randomized clinical trial. The
two interventions are based on prior evidence-informed engagement strategies: 1) educational interventions
and 2) interventions that use a peer transition advocate who prepares the adolescent and their parents for
transition. We will enroll 300 patients (150 patients in each arm). The sites will be randomized to an
intervention. The primary outcome will be successful transition, keeping two follow-up appointments within a
nine months period following transition. Secondary outcomes, as recommended by focus group participants
will also be measured. To examine the potential role of social network components and characteristics of both
egos and alters on primary outcomes, a Generalized Estimating Equation (GEE) approach will be used to
explore the associations between primary outcomes and factors at the ego, alter, and network levels. The
finding from this study will guide institution of best practices for transitioning adolescents in Nigeria and other
countries lower and middle income countries with similar challenges and potential for high impact.
新出现的成年艾滋病毒感染者面临的一个独特挑战是,他们的护理从长期的
长期儿科艾滋病毒提供者在成人艾滋病毒项目治疗。虽然从概念上说,
儿科到成人护理似乎很简单,但现实是,过渡往往是一个非常困难的过程。
过程转型不成功的后果可能从困难到灾难性。的
以青少年为中心的艾滋病病毒向成年人转变(ADAPT)研究是一项创新的随机试验,
针对护理差距的干预措施,这些差距是抗逆转录病毒治疗连续护理级联中损失的主要驱动因素,
儿童和青少年面临的问题是,越来越多的青少年错过了让青少年参与护理的机会。的具体目标
适应行动的主要目的是:(a)为资源有限环境下的过渡服务战略提供信息;(B)审查
预测成功过渡的发展、临床和其他因素;以及(c)获得基本的
通过自我网络的应用深入了解非洲青少年中的实施障碍
明确的社会支持,为结构化干预的目标提供信息。我们的多PI团队包括强大的
在儿科和青少年艾滋病护理、流行病学和社会科学方面的互补专业知识。ADAPT将
在中部、南部和北方尼日利亚的选定地点进行,
人类病毒学,尼日利亚。为了实现目标1,我们将进行六个重点小组,包括:青少年患者,
父母和医护人员。为了实现目标2,我们将进行一项随机分组临床试验。的
两项干预措施是基于先前的循证参与战略:1)教育干预措施
和2)干预措施,使用同伴过渡倡导者谁准备青少年和他们的父母,
过渡我们将入组300例患者(每组150例患者)。研究中心将随机分配至
干预主要成果将是成功过渡,在一年内保持两次后续预约,
过渡期后的9个月。焦点小组参与者建议的次要结局
也将被衡量。研究社交网络组件的潜在作用以及两者的特征
自我和改变的主要结果,广义估计方程(GEE)的方法将用于
探索主要结果与自我、改变和网络层面因素之间的关联。的
这项研究的结果将指导尼日利亚和其他国家的过渡期青少年的最佳做法。
这些国家是具有类似挑战和潜在重大影响的中低收入国家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manhattan E Charurat其他文献
Manhattan E Charurat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manhattan E Charurat', 18)}}的其他基金
Integrated Networks of Scholars in Global Health Research Training (INSIGHT) ODP supplement
全球卫生研究培训综合学者网络 (INSIGHT) ODP 补充
- 批准号:
10892423 - 财政年份:2023
- 资助金额:
$ 28.17万 - 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
- 批准号:
10705316 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT)
全球健康研究培训学者综合网络(INSIGHT)
- 批准号:
10589859 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT) ODSS supplement
全球卫生研究培训学者综合网络 (INSIGHT) ODSS 补充
- 批准号:
10874249 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
- 批准号:
10541071 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria
尼日利亚艾滋病毒感染者中性少数群体和性别少数群体中非传染性疾病、耻辱、抑郁和物质不安全感的协同流行
- 批准号:
10674991 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT)
全球健康研究培训学者综合网络(INSIGHT)
- 批准号:
10473166 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria
尼日利亚艾滋病毒感染者中性少数群体和性别少数群体中非传染性疾病、耻辱、抑郁和物质不安全感的协同流行
- 批准号:
10540034 - 财政年份:2022
- 资助金额:
$ 28.17万 - 项目类别:
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)
非 B HIV-1 亚型对非洲二线蛋白酶抑制剂治疗方案的影响 (INSPIRE)
- 批准号:
10556406 - 财政年份:2020
- 资助金额:
$ 28.17万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 28.17万 - 项目类别:
Research Grant